PubRank

J Y Mary

Author PubWeight™ 69.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996 3.15
2 Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990 2.58
3 Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996 2.41
4 Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut 1994 2.03
5 Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol 1990 2.02
6 Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. Blood 2001 1.95
7 A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1997 1.85
8 Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology 1993 1.71
9 Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut 1985 1.60
10 Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001 1.58
11 Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2005 1.58
12 Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 1998 1.56
13 Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol 1997 1.49
14 Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001 1.44
15 Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 1995 1.39
16 Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? Gut 1997 1.38
17 Planning a reproducibility study: how many subjects and how many replicates per subject for an expected width of the 95 per cent confidence interval of the intraclass correlation coefficient. Stat Med 2001 1.30
18 A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol 1999 1.27
19 Epidemiology of aplastic anemia in France: a case-control study. I. Medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 1993 1.22
20 Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001 1.19
21 Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol 2011 1.09
22 Comparison of weight- and height-based indices for assessing the risk of death in severely malnourished children. Am J Epidemiol 1996 1.03
23 A model to standardise mortality of severely malnourished children using nutritional status on admission to therapeutic feeding centres. Eur J Clin Nutr 1997 1.01
24 Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology 1996 1.00
25 Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000 0.97
26 Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man. Eur J Clin Invest 1972 0.96
27 A convenient source of CFU-s inhibitors: the fetal calf liver. Cell Tissue Kinet 1984 0.88
28 Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2001 0.88
29 Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 1986 0.88
30 Protection of mice against lethal doses of 1 beta-D-arabinofuranosylcytosine by pluripotent stem cell inhibitors. Cancer Res 1982 0.86
31 Effects of synthetic human gastrin I on movements on water, electrolytes, and glucose across the human small intestine. Gastroenterology 1976 0.84
32 [Factors related to 30th day mortality in upper digestive tract hemorrhage in cirrhotic patients (author's transl)]. Gastroenterol Clin Biol 1980 0.84
33 Further studies on prostaglandin E1-induced jejunal secretion of water and electrolytes in man, with special reference to the influence of ethacrynic acid, furosemide, and aspirin. Gastroenterology 1976 0.84
34 Down modulation of TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta 2005 0.83
35 Incubation time for AIDS from French transfusion-associated cases. Nature 1989 0.83
36 Gastrin cell distribution in normal human stomachs and in patients with Zollinger-Ellison syndrome. Gastroenterology 1978 0.83
37 Effect of feeding yogurt versus milk in children with persistent diarrhea. J Pediatr Gastroenterol Nutr 1990 0.83
38 Global and partial agreement among several observers. Stat Med 1998 0.82
39 [Effect of prostaglandin E 1 on transit time and net and unidirectional movements of water and electrolytes in the human jejunum]. Biol Gastroenterol (Paris) 1972 0.82
40 Adult patients presenting with pancytopenia: a reappraisal of underlying pathology and diagnostic procedures in 213 cases. Hematol Pathol 1989 0.82
41 Upper digestive tract hemorrhage in cirrhotic patients. Contribution of multidimensional analysis to the study of variables related to the cause of the hemorrhage. Dig Dis Sci 1981 0.81
42 Normal human granulopoiesis revisited. II. Bone marrow data. Biomed Pharmacother 1985 0.81
43 Effect of pentagastrin upon movements of water, electrolytes and glucose across the human jejunum and ileum. Digestion 1973 0.80
44 Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia. Blood 1986 0.80
45 Cell cycle models and mother-daughter correlation. J Theor Biol 1988 0.79
46 Gestational age determination and prevention of HIV perinatal transmission. Int J Gynaecol Obstet 2005 0.79
47 The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors. Stem Cells 1993 0.79
48 Mathematical analysis of bone marrow erythropoiesis: application to C3H mouse data. Blood Cells 1980 0.78
49 Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002 0.78
50 Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci 1995 0.78
51 [Intestinal absorption of vitamin D, linoleic acid and cholesterol from micellar solutions: study in normal humans by the "in situ" perfusion method]. Biol Gastroenterol (Paris) 1976 0.77
52 Interleukin 2 interacts with myeloid growth factors in serum-free long-term bone marrow culture. Br J Haematol 1994 0.77
53 Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp Hematol 1990 0.77
54 Risk factors for fatal diarrhoea among dehydrated malnourished children in a Madagascar hospital. Eur J Clin Nutr 1995 0.77
55 Modifications of hemato-biological parameters in pregnant women in a migrating population in northern Cameroon: prevalence of anemia, iron and folates deficiencies. Int J Vitam Nutr Res 1987 0.77
56 In vivo protection of normal mouse hematopoiesis by a beta 2 blocking agent during S-phase chemotherapy. Cancer Res 1984 0.76
57 [Is the dilution of milk necessary in benign acute diarrhea in eutrophic infants?]. Arch Fr Pediatr 1989 0.76
58 [Clinical consequences of replacing milk with yogurt in persistent infantile diarrhea]. Ann Pediatr (Paris) 1992 0.76
59 Normal human granulopoiesis revisited. I. Blood data. Biomed Pharmacother 1984 0.76
60 Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 1996 0.76
61 Calprotectin and IBD. Gut 2005 0.75
62 [Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]. Ann Gastroenterol Hepatol (Paris) 1993 0.75
63 Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients. Br J Cancer 1989 0.75
64 Automatic search for model to simulate the differentiation of T lymphocytes within the thymus. Acta Biotheor 1992 0.75
65 Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557). Bone Marrow Transplant 1987 0.75
66 Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation. Bone Marrow Transplant 1991 0.75
67 Sex-dependent effects of non-H-2 loci on lethal GVH reaction induced across an H-2 barrier. Immunogenetics 1986 0.75
68 [Does parenteral nutrition-induced fatty liver depend on the amount of glucose supplied? (author's transl)]. Gastroenterol Clin Biol 1977 0.75
69 [Mixed lympho-epidermal cell cultures: value in bone marrow grafts]. Presse Med 1989 0.75
70 Revisiting statistical methods to assess the effect of hematopoietic inhibitors using colony-forming assays. Ann N Y Acad Sci 1991 0.75
71 [Validity of the D-xylose test for the detection of the proximal small intestine lesions. Statistical study of the discriminant parameters and of their cut-off values (author's transl)]. Biol Gastroenterol (Paris) 1976 0.75
72 [Effect of pentagastrin on intestinal absorption in man]. Biol Gastroenterol (Paris) 1971 0.75
73 Size and weight study of human kidney growth velocity during the last three months of pregnancy. Eur Urol 1980 0.75
74 Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557). Exp Hematol 1989 0.75
75 Risk factors for A.I.D.S. among homosexual men in France. Eur J Epidemiol 1988 0.75
76 [Leukocyte differential of the Coulter VCS. Evaluation and modalities of use in comparison with the Coulter STKR and manual count]. Ann Biol Clin (Paris) 1990 0.75
77 [Value of multidimensional analysis in clinical research]. Rev Prat 1983 0.75
78 Growth fraction of myelocytes in normal human granulopoiesis. Cell Tissue Kinet 1986 0.75
79 Kappa as an index of reproducibility: distribution under the null-hypothesis. Rev Epidemiol Sante Publique 1987 0.75
80 [Glycosylated hemoglobin and blood viscosity]. Journ Annu Diabetol Hotel Dieu 1979 0.75
81 Conditions of validation and use of the screening method for vaccine efficacy evaluation. Rev Epidemiol Sante Publique 1993 0.75
82 A classification after radical cystectomy of patients with bladder cancer associated with schistosomiasis. Eur J Cancer 1994 0.75
83 Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557. Exp Hematol 1987 0.75
84 [Method of computer analysis of labelled mitosis curves]. Biomedicine 1973 0.75
85 Is P50 the most representative P(SO2) to evaluate HbO2 affinity? Scand J Clin Lab Invest Suppl 1990 0.75
86 A French cluster of Creutzfeldt-Jakob disease: a molecular analysis. Eur J Neurol 2002 0.75
87 Towards an objective prognostic index of acute graft-versus-host disease. Anal Cell Pathol 1993 0.75
88 [Experimental bases of the in vitro treatment of leukemic bone marrow by a derivative of cyclophosphamide: ASTA Z 7557]. C R Acad Sci III 1985 0.75
89 Decrease in the ability of CFU-s in shielded marrow to be recruited into cell cycle after multiple irradiations: experimental results and computer simulations. Cell Tissue Kinet 1984 0.75
90 Long-term effects of high doses of cytosine arabinoside on pluripotent stem cells (CFU-S). Exp Hematol 1989 0.75
91 In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation. Exp Hematol 1993 0.75
92 A case-control study of aplastic anaemia: occupational exposures. The French Cooperative Group for Epidemiological Study of Aplastic Anaemia. Int J Epidemiol 1995 0.75
93 Proceedings: The influence of ethacrynic acid and aspirin on water and electrolyte secretion induced by prostaglandin E1 in the human jejunum. Gut 1974 0.75
94 [Value of the D-xylose test in disorders of the intestinal mucosa and use of French in medical publications]. Nouv Presse Med 1976 0.75
95 Relationship between vitamin A and malignancy in cancer patients. Int J Vitam Nutr Res 1985 0.75
96 Statistical analysis of splenic colony histology: an attempt to confirm that external factors could affect the channelling of CFUS differentiation. Exp Hematol 1983 0.75
97 Risk factors for AIDS among homosexual men in a moderate incidence area. Int J Epidemiol 1987 0.75
98 The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients. Br J Haematol 1988 0.75
99 Power calculation for the likelihood ratio-test when comparing two dependent intraclass correlation coefficients. Comput Methods Programs Biomed 2005 0.75
100 Presence of elevated serum interleukin-2 levels in pregnant women. N Engl J Med 1990 0.75